Oncolytics Biotech (ONCY) Receiving Somewhat Favorable News Coverage, Study Shows


Media headlines about Oncolytics Biotech have been trending somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources.



from Biotech News